Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age

Clinical trial NCT00174252 · COMPLETED

Trial details

NCT number: NCT00174252
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Fetal Growth Retardation

Start date: 2005-02-01
Primary completion: 2009-04-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.